People · Operator
Named in public records as an officer, director or promoter · active 2016–2025 · Biotechnology, Software / Tech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Nutcracker Therapeutics, Inc. | — | Biotechnology | Series D+ | $172.5M | $4.1B | 2018 |
| Berkeley Lights, Inc. | — | Biotechnology | Series C | $73.8M | $1.8B | 2016 |
| nEye Systems, Inc. | — | Software / Tech | Series C | $72.5M | $454.7M | 2025 |
Igor Khandros at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Igor Khandros on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Stuart Merkadeau | 2 | 2 |
| Ming Wu | 2 | 2 |
| Robert Nelsen | 1 | 22 |
| Michael Marks | 1 | 20 |
| Michael Moritz | 1 | 7 |
| James Zhu | 1 | 4 |
| Eric Hayes | 1 | 3 |
| James Luo | 1 | 3 |
| Madhavan Balachandran | 1 | 3 |
| William Davidow | 1 | 2 |
| Makoto Shintani | 1 | 2 |
| Shaun Holt | 1 | 2 |
| Lip-Bu Tan Tan | 1 | 1 |
| Benjamin Eldridge | 1 | 1 |
| Samuel Deutsch | 1 | 1 |
| Andy Last | 1 | 1 |
| Eric Hobbs | 1 | 1 |
| John Gunn | 1 | 1 |
| James Rothman | 1 | 1 |
| Igor Khandros, Ph.D. | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.